Search - tctmd.com

Displaying 1 - 20 of 62

Sort: Relevancy | Date

Presentation TCT 2025

TCT 124: Enhanced Prediction of Pacemaker Implantation Post-TAVI Using Pre-Procedural CTA, ECG, Device Characteristics, and Fluoroscopic Implant Depth

Presenter: Karan Rao

October 28, 2025

Presentation TCT 2025

TCT 123: Timing And Typology of ConducTIon disturbanCes during TAVR

Presenter: Matteo Maurina

October 28, 2025

Presentation TCT 2025

TCT 119: Impact of Depth of implantation to Membranous Interventricular Septum Ratio on the Incidence of Conduction Disturbance after Transcatheter Aortic Valve Replacement

Presenter: Ayman K M. Hassan

October 28, 2025

Presentation TCT 2025

TCT 120: Association of Left Bundle Branch Block with Long Term Adverse Outcomes Following TAVR

Presenter: Mangesh Kritya

October 28, 2025

Presentation TCT 2025

TCT 121: Pacemaker Post-TAVR: Evaluation of Clinical Outcomes and the Impact of Implantation Timing

Presenter: Nicholas Joseph Valle

October 28, 2025

Presentation TCT 2025

Incidence and Clinical Consequences of Conduction Disturbances After TAVR

Presenter: Amit N. Vora

October 28, 2025

Presentation TCT 2025

TCT 116: Burden of Tricuspid Valve Regurgitation in Early Pacemaker Recipients After TAVR: A Single Center Study

Presenter: Massimo Baudo

October 26, 2025

Presentation TCT 2025

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

Presenter: Chaitanya Tumuluri

October 26, 2025

Presentation TCT 2025

TCT 114: Impact of New Pacemaker Implantation After TAVR in Low/Intermediate-Risk Patients: A Propensity-Matched Analysis from a United States Registry

Presenter: Roger Renault Godinho

October 26, 2025

Presentation TCT 2025

TCT 113: Changing Patterns of Pacemaker Implantation After TAVR: Insights From the CENTER2 Study

Presenter: Gijs Broeze

October 26, 2025

Presentation TCT 2025

TCT 115: Five-Year Impact of New Pacemaker Implantation After TAVR: A Propensity-Matched Analysis from a United States Registry

Presenter: Carlos Campos

October 26, 2025

Presentation NY Valves 2025

Incidence and Clinical Implications of Conduction Disturbances After TAVR and Post Procedural Management

Presenter: Tamim M. Nazif

June 26, 2025

Presentation TCT 2024

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

TCT 125: Predictors of Pathological Electrophysiological Study Post-TAVI: Focusing on Changes in PR and QRS Intervals

Presenter: Paula Vela Martin

October 29, 2024

Presentation TCT 2024

TCT 122: Perioperative and In-Hospital Outcomes of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample 2016-2021

Presenter: Ankur Singla

October 29, 2024

Presentation TCT 2024

TCT 123: Is HV Interval Prior TAVR a Stronger Predictor for Permanent Pacemaker Implantation Than CT Anatomic Features?

Presenter: José Antonio Baz Alonso

October 29, 2024

Presentation TCT 2024

TCT 127: Thirty-Day High-Grade AV Block Post Transcatheter Aortic Valve Replacement in Patients Discharged on Heart Rhythm Monitor

Presenter: Mohamad Saleh Alabdaljabar

October 29, 2024

Presentation TCT 2024

TCT 126: Anticoagulation Therapy in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Presenter: Koki Takegawa

October 29, 2024

Presentation TCT 2024

TCT 131: In-Hospital, 1-Year and Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients Requiring Permanent Pacemaker Implantation

Presenter: Sindhuja Palle

October 29, 2024

Presentation TCT 2024

TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR)

Presenter: Bruce Adrian Casipit

October 29, 2024

Advertisement

TCT 124: Enhanced Prediction of Pacemaker Implantation Post-TAVI Using Pre-Procedural CTA, ECG, Device Characteristics, and Fluoroscopic Implant Depth

TCT 123: Timing And Typology of ConducTIon disturbanCes during TAVR

TCT 119: Impact of Depth of implantation to Membranous Interventricular Septum Ratio on the Incidence of Conduction Disturbance after Transcatheter Aortic Valve Replacement

TCT 120: Association of Left Bundle Branch Block with Long Term Adverse Outcomes Following TAVR

TCT 121: Pacemaker Post-TAVR: Evaluation of Clinical Outcomes and the Impact of Implantation Timing

Incidence and Clinical Consequences of Conduction Disturbances After TAVR

TCT 116: Burden of Tricuspid Valve Regurgitation in Early Pacemaker Recipients After TAVR: A Single Center Study

TCT 117: Contemporary Trends in Mortality and Resource Utilization in Atrial Fibrillation Versus Non-Atrial Fibrillation in Transcatheter Aortic Valve Replacement: A National Study

TCT 114: Impact of New Pacemaker Implantation After TAVR in Low/Intermediate-Risk Patients: A Propensity-Matched Analysis from a United States Registry

TCT 113: Changing Patterns of Pacemaker Implantation After TAVR: Insights From the CENTER2 Study

TCT 115: Five-Year Impact of New Pacemaker Implantation After TAVR: A Propensity-Matched Analysis from a United States Registry

Incidence and Clinical Implications of Conduction Disturbances After TAVR and Post Procedural Management

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

TCT 125: Predictors of Pathological Electrophysiological Study Post-TAVI: Focusing on Changes in PR and QRS Intervals

TCT 122: Perioperative and In-Hospital Outcomes of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample 2016-2021

TCT 123: Is HV Interval Prior TAVR a Stronger Predictor for Permanent Pacemaker Implantation Than CT Anatomic Features?

TCT 127: Thirty-Day High-Grade AV Block Post Transcatheter Aortic Valve Replacement in Patients Discharged on Heart Rhythm Monitor

TCT 126: Anticoagulation Therapy in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Replacement

TCT 131: In-Hospital, 1-Year and Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients Requiring Permanent Pacemaker Implantation

TCT 132: Impact of Comorbid Heart Failure With Reduced Ejection Fraction (HFrEF) in the Development of Arrhythmias Among Patients Hospitalized for Transcatheter Aortic Valve Replacement (TAVR)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content